Myriad Genetics Inc

MYGNStocksMedical SpecialtiesUnited StatesNasdaqUSD

Price

$4.27

Today

-6.6%

YTD

-30.4%

About

Myriad Genetics, Inc. is an esteemed company specialising in the cutting-edge field of molecular diagnostic testing. Its operations extend globally. The firm provides genetic, molecular and companion diagnostic testing services. As a global leader in personalised medicine, Myriad Genetics pioneers its work in the healthcare industry with high-quality diagnostic tools and gene tests. The company specialises in hereditary cancer risk, reproductive health, oncology, urology and mental health. Myriad Genetics is known for BRACAnalysis CDx, EndoPredict and Foresight. Monitor the MYGN share price by adding it to your eToro watchlist.

Price chart

Closing price history for MYGN (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-3.82

P/S (TTM)0.54

P/B (TTM)1.44

Market cap$438.08M

Cap tierSmall-cap

Industry avg P/E17.60

Profitability

Gross margin65.10%

EBIT margin-11.22%

Net margin-22.65%

ROE-32.54%

ROA-17.11%

Earnings & Revenue

Revenue (TTM)$806.60M

Revenue growth (1Y)-3.2%

EPS (TTM)-$1.20

Free cash flow$-7.30M

Total debt$210.50M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.13

Employees2,700

Next earnings2 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.